Implementation of a pharmacological prophylaxis bundle to prevent obstetric-associated venous thromboembolism.

Purpose: Venous thromboembolism (VTE) accounts for a significant proportion of pregnancy-related mortality. In response to a series of VTEs at our institution and in accordance with mounting medical evidence for increased assessment, we implemented a universal, standardized obstetric VTE risk assessment process during antepartum and postpartum admissions and corresponding pharmacological thromboprophylaxis, which extends into the postdischarge period to prevent pregnancy-associated VTE in our urban, safety-net population.

Summary: This quality improvement (QI) project used the Institute for Healthcare Improvement's Model for Improvement.